NYSE:ATHAthene Stock Price, Forecast & News

Athene's stock was trading at $31.16 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ATH stock has increased by 13.6% and is now trading at $35.41.
View which stocks have been most impacted by Coronavirus.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Athene.

Athene is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Athene.

Athene Holding Ltd (NYSE:ATH) issued its quarterly earnings data on Wednesday, August, 5th. The insurance provider reported $2.49 EPS for the quarter, topping the consensus estimate of $1.90 by $0.59. The insurance provider had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $940.68 million. Athene had a net margin of 13.50% and a return on equity of 7.93%. Athene's revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.95 earnings per share.
View Athene's earnings history.

9 brokers have issued twelve-month target prices for Athene's shares. Their forecasts range from $34.00 to $72.00. On average, they expect Athene's stock price to reach $44.67 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price.
View analysts' price targets for Athene.

News stories about ATH stock have trended very negative this week, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Athene earned a news sentiment score of -3.4 on InfoTrie's scale. They also gave media stories about the insurance provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about Athene.

Some companies that are related to Athene include Prudential Financial (PRU), SWISS RE LTD/S (SSREY), Sun Life Financial (SLF), AVIVA PLC/ADR (AVVIY), Legal & General Group (LGEN), SONY FINL HOLDI/ADR (SNYFY), Globe Life (GL), AEGON (AEG), Lincoln National (LNC), Voya Financial (VOYA), Reinsurance Group of America (RGA), Primerica (PRI), AMP (AMP), Brighthouse Financial (BHF) and American Equity Investment Life (AEL).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include Visa (V), AT&T (T), Alibaba Group (BABA), Walt Disney (DIS), JD.Com (JD), Okta (OKTA), AbbVie (ABBV), Netflix (NFLX), Advanced Micro Devices (AMD) and Cisco Systems (CSCO).

(ATH) raised $952 million in an initial public offering on Friday, December 9th 2016. The company issued 23,800,000 shares at a price of $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Athene's stock is owned by many different institutional and retail investors. Top institutional investors include Assenagon Asset Management S.A. (0.75%), Serengeti Asset Management LP (0.30%), Swiss National Bank (0.29%), First Trust Advisors LP (0.23%), New York State Common Retirement Fund (0.15%) and Strs Ohio (0.10%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, James Richard Belardi, Lawrence Ruisi, Marc A Beilinson, Martin P Klein and Robert L Borden.
View institutional ownership trends for Athene.

ATH stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Robeco Institutional Asset Management B.V., WINTON GROUP Ltd, New York State Common Retirement Fund, Andra AP fonden, Zurcher Kantonalbank Zurich Cantonalbank, Principal Financial Group Inc., and Strs Ohio. Company insiders that have sold Athene company stock in the last year include Frank Lauren Gillis, Lawrence Ruisi, and Robert L Borden.
View insider buying and selling activity for Athene.

ATH stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., UBS Group AG, Picton Mahoney Asset Management, First Trust Advisors LP, Sciencast Management LP, Denali Advisors LLC, Oregon Public Employees Retirement Fund, and Rafferty Asset Management LLC. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein.
View insider buying and selling activity for Athene.

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ATH stock can currently be purchased for approximately $35.41.

Athene has a market capitalization of $6.88 billion and generates $16.26 billion in revenue each year. The insurance provider earns $2.17 billion in net income (profit) each year or $6.94 on an earnings per share basis. Athene employs 1,325 workers across the globe.

The official website for Athene is www.athene.com.

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at 441-279-8400 or via email at [email protected]